Early Phase 1 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form before any study activities begin
- Women who could become pregnant must either not be sexually active or use 2 forms of contraception (at least one barrier method, such as a condom) during the study and for 90 days after the last injection
- Men must use 2 forms of contraception and must not donate sperm during the study and for 90 days after the last injection
- If you have Parkinson's disease or are in a healthy elderly comparison group, you must be between 40 and 80 years old; if you are in a healthy young comparison group, you must be between 18 and 50 years old
- You must have adequate blood flow and normal blood clotting ability, which may be relevant if a procedure involving an artery is needed (confirm with trial site)
- If you are in the healthy elderly comparison group, you must have no neurological condition and no close family member (parent, sibling, or child) with Parkinson's disease
- If you are in the healthy young comparison group, you must be in good health with no significant medical findings
Who may not be able to join:
- People who are unwilling or unable to give their informed consent
- People with a significant illness affecting the liver, kidneys, heart, lungs, or overall health
- People who are pregnant or currently breastfeeding
- People who cannot have a PET scan or MRI, for example due to certain implants in the body or fear of enclosed spaces
- People who have had a serious allergic reaction to PET scan tracers or similar substances in the past
- People who have taken part in another trial involving an experimental drug within the last 30 days
- People with any condition that could affect how the study runs or put their safety at risk (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 203-401-4300
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of [18F]MK-0947: Incidence of Adverse Events; Safety of [18F]MK-0947: Radiation absorbed dose estimates
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.